BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21272259)

  • 1. Efficacy of cytokine removal by plasmadiafiltration using a selective plasma separator: in vitro sepsis model.
    Li M; Xue J; Liu J; Kuang D; Gu Y; Lin S
    Ther Apher Dial; 2011 Feb; 15(1):98-108. PubMed ID: 21272259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.
    Mariano F; Fonsato V; Lanfranco G; Pohlmeier R; Ronco C; Triolo G; Camussi G; Tetta C; Passlick-Deetjen J
    Nephrol Dial Transplant; 2005 Jun; 20(6):1116-26. PubMed ID: 15814541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solute removal capacity of high cut-off membrane plasma separators.
    Ohkubo A; Kurashima N; Nakamura A; Miyamoto S; Iimori S; Rai T
    Ther Apher Dial; 2013 Oct; 17(5):484-9. PubMed ID: 24107276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous plasma filtration coupled with sorbents.
    Tetta C; Cavaillon JM; Camussi G; Lonnemann FG; Brendolan A; Ronco C
    Kidney Int Suppl; 1998 May; 66():S186-9. PubMed ID: 9573601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.
    Gogos CA; Drosou E; Bassaris HP; Skoutelis A
    J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial.
    Haase M; Bellomo R; Baldwin I; Haase-Fielitz A; Fealy N; Davenport P; Morgera S; Goehl H; Storr M; Boyce N; Neumayer HH
    Am J Kidney Dis; 2007 Aug; 50(2):296-304. PubMed ID: 17660031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in inflammatory mediators following eccentric exercise of the elbow flexors.
    Hirose L; Nosaka K; Newton M; Laveder A; Kano M; Peake J; Suzuki K
    Exerc Immunol Rev; 2004; 10():75-90. PubMed ID: 15633588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory cytokine levels in patients with septic shock.
    Kasai T; Inada K; Takakuwa T; Yamada Y; Inoue Y; Shimamura T; Taniguchi S; Sato S; Wakabayashi G; Endo S
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):34-42. PubMed ID: 9434313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balanced ultrafiltration: inflammatory mediator removal capacity.
    Guan Y; Wan C; Wang S; Sun P; Long C
    Artif Organs; 2012 Oct; 36(10):894-900. PubMed ID: 22817761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis.
    Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
    Crit Care Med; 1994 Oct; 22(10):1595-602. PubMed ID: 7924371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of 17 cytokines, HMGB1, and albumin by continuous hemofiltration using a cellulose triacetate membrane: an ex vivo study.
    Yasuda N; Goto K; Yamamoto S; Hidaka S; Hagiwara S; Noguchi T
    J Surg Res; 2012 Jul; 176(1):226-31. PubMed ID: 22099603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model.
    Hildebrand F; Pape HC; Hoevel P; Krettek C; van Griensven M
    Shock; 2003 Oct; 20(4):338-46. PubMed ID: 14501948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration.
    Yumoto M; Nishida O; Moriyama K; Shimomura Y; Nakamura T; Kuriyama N; Hara Y; Yamada S
    Ther Apher Dial; 2011 Aug; 15(4):385-93. PubMed ID: 21884474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines and soluble cytokine receptors in the perioperative period].
    Maruna P; Gürlich R; Frasko R; Chachkhiani I; Marunová M; Owen K; Pesková M
    Sb Lek; 2002; 103(2):273-82. PubMed ID: 12688152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome.
    Vindenes HA; Ulvestad E; Bjerknes R
    Eur J Surg; 1998 Sep; 164(9):647-56. PubMed ID: 9728783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis.
    Peng Y; Yuan Z; Li H
    Burns; 2005 Aug; 31(5):623-8. PubMed ID: 15975721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study.
    Graziani G; Bordone G; Bellato V; Finazzi S; Angelini C; Badalamenti S;
    J Nephrol; 2006; 19(2):176-82. PubMed ID: 16736416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.